Youyou J. Yan

Key Laboratory Of Clinical Cancer Pharmacology And Toxicology Research Of Zhejiang Province
Hangzhou, 310006, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Cyclofenil blocks the secretion of IL-1β by inhibiting assembly of the NLRP3 inflammasome independent of estrogen receptor.

Cyclofenil blocks the secretion of IL-1β by inhibiting assembly of the NLRP3 inflammasome independent of estrogen receptor.

Journal: Molecular biology reports
Published: May 18, 2026

The Effect of AZD5153 on Radiosensitivity in Pancreatic Cancer Cells Through ATM-chk1 Pathway.

The Effect of AZD5153 on Radiosensitivity in Pancreatic Cancer Cells Through ATM-chk1 Pathway.

Journal: Drug design, development and therapy
Published: October 13, 2025

Anti-tumor efficacy of RAF/MEK inhibitor VS6766 in KRAS-mutated colorectal cancer cells.

Anti-tumor efficacy of RAF/MEK inhibitor VS6766 in KRAS-mutated colorectal cancer cells.

Journal: Cancer chemotherapy and pharmacology
Published: May 23, 2025

AZD5153 enhances the chemo-sensitivity of gemcitabine on pancreatic cancer cells in vitro and in vivo.

AZD5153 enhances the chemo-sensitivity of gemcitabine on pancreatic cancer cells in vitro and in vivo.

Journal: Cancer cell international
Published: March 03, 2025

The cytoskeletal protein smoothelin maintains homologous recombination repair by stabilizing RAD51 in an HUWE1-dependent manner in colorectal cancer.

The cytoskeletal protein smoothelin maintains homologous recombination repair by stabilizing RAD51 in an HUWE1-dependent manner in colorectal cancer.

Journal: Acta pharmaceutica Sinica. B
Published: February 12, 2025

Milciclib-mediated CDK2 inhibition to boost radiotherapy sensitivity in colorectal cancer.

Milciclib-mediated CDK2 inhibition to boost radiotherapy sensitivity in colorectal cancer.

Journal: Frontiers in pharmacology
Published: January 09, 2025

Multiplexed imaging mass cytometry elicits p-S6 as a therapeutic and prognostic factor in diffuse large B-cell lymphoma.

Multiplexed imaging mass cytometry elicits p-S6 as a therapeutic and prognostic factor in diffuse large B-cell lymphoma.

Journal: Blood advances
Published: December 02, 2024

Hepatotoxicity of epidermal growth factor receptor - tyrosine kinase inhibitors (EGFR-TKIs).

Hepatotoxicity of epidermal growth factor receptor - tyrosine kinase inhibitors (EGFR-TKIs).

Journal: Drug metabolism reviews
Published: August 09, 2024

Injectable and Sprayable Fluorescent Nanoprobe for Rapid Real-Time Detection of Human Colorectal Tumors.

Injectable and Sprayable Fluorescent Nanoprobe for Rapid Real-Time Detection of Human Colorectal Tumors.

Journal: Advanced materials (Deerfield Beach, Fla.)
Published: April 12, 2024

HZ-A-018, a novel inhibitor of Bruton tyrosine kinase, exerts anti-cancer activity and sensitizes 5-FU in gastric cancer cells.

HZ-A-018, a novel inhibitor of Bruton tyrosine kinase, exerts anti-cancer activity and sensitizes 5-FU in gastric cancer cells.

Journal: Frontiers in pharmacology
Published: January 11, 2023

Ibrutinib-Associated Cardiotoxicity: From the Pharmaceutical to the Clinical.

Ibrutinib-Associated Cardiotoxicity: From the Pharmaceutical to the Clinical.

Journal: Drug design, development and therapy
Published: June 07, 2022

The Ibr-7 derivative of ibrutinib radiosensitizes pancreatic cancer cells by downregulating p-EGFR.

The Ibr-7 derivative of ibrutinib radiosensitizes pancreatic cancer cells by downregulating p-EGFR.

Journal: Cancer cell international
Published: May 29, 2020
Showing 1-12 of 23

Last Updated: 09/26/2026